Company Overview of Camel-IDS NV
Camel-IDS NV, a biotech company, develops radionuclide therapeutic solutions for cancer patients. The company offers a technology platform that allows fast and specific delivery of therapeutic radiation to cancer cells. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.
Rue Vandenboogaerde, 25
Founded in 2014
32 4 73 45 45 93
Key Executives for Camel-IDS NV
Camel-IDS NV does not have any Key Executives recorded.
Camel-IDS NV Key Developments
Similar Private Companies By Industry
|A-Mansia Biotech S.A.||Europe|
|ADx NeuroSciences NV||Europe|
|Aelin Therapeutics NV||Europe|
|Apitope International NV||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Camel-IDS NV, please visit www.camel-ids.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.